Net gamma exposure for Amphastar Pharmaceuticals Inc (AMPH) options was positive at the Nov 20, 2026 close, about $4.22K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for AMPH, 2026-12-18(m), calls & puts
Gamma Exposure Stats
Showing results for AMPH, 2026-12-18(m), calls & puts
| Net GEX ($ per 1% move) | $0 |
|---|---|
| Call GEX ($ per 1% move) | $0 |
| Put GEX ($ per 1% move) | $0 |
| Call Wall | |
| Put Wall | |
| Gamma Flip (Zero Gamma) |
Net Gamma Exposure by Expiration
Showing results for AMPH, 2026-12-18(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|---|---|---|---|---|---|
| Dec 18, 2026 26 DTE monthly | $0 | $0 | $0 |
AMPH Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is AMPH gamma exposure positive or negative?
Amphastar Pharmaceuticals net gamma exposure was positive on Nov 20, 2026, at $4.22K. It has been positive on 20 of the last 20 trading days.
How has AMPH gamma exposure changed recently?
Amphastar Pharmaceuticals net gamma exposure went from $6.22K on Oct 23, 2026 to $4.22K on Nov 20, 2026. That is its lowest reading in 8 weeks. See the AMPH gamma exposure history for a longer view.
What is Amphastar Pharmaceuticals Inc?
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products.